| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ad4c9403364a2277dc906d5bc5642e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1725 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6d9cc44fa38423a0de17d7ea62e189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7afcc4d5d02c7b87760f0a11ec1cc074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ba0ab3cf0565a5da1f94614905f159 |
| publicationDate |
2020-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200009907-A |
| titleOfInvention |
Composition for treating neuroinflammatory disease comprising complement component 8 gamma or fragment thereof |
| abstract |
The present invention relates to a composition for treating neuroinflammatory diseases comprising a complement component 8 gamma protein or a fragment thereof, and more particularly, the effect of reducing the expression of inflammatory cytokines in microglia. The present invention relates to the use of complement component 8 gamma or fragment thereof for treating neuroinflammatory diseases. The composition of the present invention is effective in reducing Alzheimer's abnormal behavior and reducing the secretion of neuroinflammatory cytokines in brain microglia, which can be very useful for the prevention or treatment of neuroinflammatory diseases. |
| priorityDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |